I mercati dell'Italia hanno chiuso

Aptose Biosciences Inc (LTI.BE)

Berlin - Berlin Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
0,3640-0,0080 (-2,15%)
Alla chiusura: 08:22PM CEST
Schermo intero
Chiusura precedente0,3720
Aperto0,3580
Denaro0,3200 x N/D
Domanda0,3900 x N/D
Min-Max giorno0,3540 - 0,3680
Intervallo di 52 settimane0,3040 - 3,0400
VolumeN/D
Media Volume0
CapitalizzazioneN/D
Beta (mensile su 5 anni)N/D
Rapporto PE (ttm)N/D
EPS (ttm)N/D
Prossima data utili07 nov 2024 - 11 nov 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Aptose Clinical and Preclinical Data to be Presented at European School of Haematology (ESH) 6th International Conference

    Company to Hold Clinical Update Webcast; Details ForthcomingSAN DIEGO and TORONTO, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today announced that two abstracts on tuspetinib, Aptose’s Phase 1/2 myeloid kinase inhibitor in development for acute myeloid leukemia (AML), have been accepted for post